TRXADE HEALTH INC (MEDS) Stock Income Statement
USA - NASDAQ:MEDS - US89846A4058 - Common Stock
7.59 USD
+0.35 (+4.83%)
7.591 USD
+0 (+0.01%)
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.43M | 8.27M | 11.45M | 9.89M | 17.12M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | 440.00K | null | null | |||
| Cost Of Goods | 4.97M | 5.67M | 6.00M | 5.14M | 11.42M | |||
| Gross Profit | -544.71K | 2.60M | 5.45M | 4.75M | 5.71M | |||
| Operating Expenses | 13.48M | 9.86M | 8.20M | 8.81M | 7.48M | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | 13.48M | 9.86M | 8.21M | 8.81M | 7.49M | |||
| Operating Income | -14.03M | -7.26M | -2.75M | -4.06M | -1.78M | |||
| Interest Income/Expense | -954.74K | -1.19M | -320.00K | -20.00K | -30.00K | |||
| Other Income/Expense | 339.73K | -133.88K | 830.00K | null | 0 | |||
| Non Recurring Items | null | -5.13M | -1.67M | -1.23M | -730.00K | |||
| Income Before Taxes | -20.15M | -13.72M | -3.91M | -5.32M | -2.54M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | 4.17M | -17.84M | -3.47M | -5.32M | -2.54M | |||
| EBITDA | -13.20M | -6.43M | -2.74M | -4.05M | -1.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.292340000000003 | -23.35 | -6.19 | -9.85 | -4.98 | |||
| Non GAAP EPS | null | null | -4.8 | -1.91 | -0.23 | |||
| Statistics | ||||||||
| Gross Profit Margin | -12.30% | 31.41% | 47.60% | 48.03% | 33.35% | |||
| Profit Margin | 94.17% | -215.70% | -30.31% | -53.79% | -14.84% | |||
| Operating Profit Margin | -316.69% | -87.80% | -24.02% | -41.05% | -10.40% | |||
All data in USD